What are the risks and side effects of starting TRT in your 30s?

Short answer Starting testosterone replacement therapy (TRT) in your 30s can help if you have true hypogonadism, but it carries several important risks — most notably suppression of fertility, testicular shrinkage, blood changes (polycythemia), possible cardiovascular effects, and other hormone-related side effects. Because you’re in your 30s, fertility and long‑term risks are often the deciding factors and need careful discussion with a clinician before starting.

Main risks and side effects

• Fertility suppression and testicular atrophy
  • Exogenous testosterone suppresses the hypothalamic–pituitary–gonadal (HPG) axis (↓ LH/FSH), often causing decreased sperm production or even temporary azoospermia. Testes may shrink. Recovery can take months to years and is not always complete. This is the biggest concern for men who want biological children.
• Erythrocytosis / polycythemia
  • TRT can raise red blood cell mass (hematocrit). High hematocrit increases risk of blood clots, stroke, or heart attack if not monitored and managed.
• Cardiovascular risk
  • Data are mixed. Some studies suggest increased risk of cardiovascular events in men with preexisting heart disease; the risk in younger otherwise healthy men is less clear but should be considered, especially if you have risk factors (smoking, hypertension, high cholesterol, obesity).
• Gynecomastia, acne, hair loss
  • Testosterone can convert to estrogen (aromatization), causing breast tissue growth or tenderness. Acne and acceleration of male‑pattern baldness can occur.
• Mood and behavior
  • Some men experience mood swings, irritability, or increased aggression; others report mood improvement. Monitor closely.
• Sleep apnea
  • TRT can worsen or unmask obstructive sleep apnea in susceptible men.
• Prostate effects
  • TRT can raise PSA and may worsen lower urinary tract symptoms (BPH). Active prostate or breast cancer is a contraindication.
• Liver effects
  • Oral 17‑alkylated androgens can cause liver toxicity; injectable and topical formulations have minimal direct liver toxicity but liver tests are monitored.
• Skin irritation and transfer
  • Topical gels/solutions can irritate skin and can be unintentionally transferred to partners/children if precautions aren’t followed.
• Injection‑related issues
  • Pain, local irritation, rare oil‑embolism risk with certain long‑acting formulations.

Baseline tests and monitoring (typical)

• Before starting: two morning total testosterone measurements, LH/FSH, prolactin if low T, CBC (hematocrit), PSA (age‑dependent), fasting glucose/HbA1c, lipid panel, liver enzymes.
• Ongoing: testosterone level ~4–12 weeks after starting/dose change, then every 3–6 months initially; CBC every 3–6 months first year then annually; PSA annually (or per urologist), lipids and metabolic labs annually.
• If hematocrit >54% or other concerning results, TRT should be paused/adjusted and managed.

Fertility-preserving alternatives and options

• If you want kids, discuss alternatives before starting:
  • Clomiphene citrate (Clomid) — an oral SERM that stimulates endogenous LH/FSH and can raise testosterone while preserving fertility in many men.
  • Human chorionic gonadotropin (hCG) — preserves intratesticular testosterone and spermatogenesis; often used with or instead of TRT for men desiring fertility.
  • Aromatase inhibitors (anastrozole) in select cases to manage estrogen conversion.
  • Sperm banking (cryopreservation) before starting TRT is a prudent option if you may want biological children.
• These options should be managed by a urologist or reproductive endocrinologist.

Formulation differences (pros/cons) and example brands

• Topical gels: AndroGel, Testim, Fortesta
  • Pros: steady daily dosing, easy to stop; cons: skin transfer risk, daily application.
• Patches: Androderm
  • Pros: steady levels; cons: skin irritation, adhesive issues.
• Short‑acting injectables: Depo‑Testosterone (testosterone cypionate), Testosterone enanthate
  • Pros: inexpensive, widely used; cons: peaks/troughs (can cause mood/energy swings).
• Long‑acting injectable: Aveed (testosterone undecanoate) / Nebido (brand outside US)
  • Pros: infrequent dosing (10–12 weeks); cons: risk of pulmonary oil microembolism (Aveed requires REMS in the US), injection-site reactions.
• Buccal: Striant
  • Pros: avoids transference; cons: local gum irritation. Pick a formulation based on lifestyle, monitoring, and side effect profile; discuss with your prescriber.

Where to get care / services (options)

• See a urologist or endocrinologist for comprehensive evaluation and fertility counseling (best for nuanced care).
• If you prefer telehealth, services such as Hims or Roman can be convenient for access to TRT, but they may not provide the full in‑person workup (make sure they do baseline labs and fertility counseling).
• For fertility preservation or assistance, use a local fertility clinic or national sperm banks (for example, Cryos International) to discuss sperm banking.

What to discuss with your doctor

• Confirmed low testosterone on repeat morning tests and whether symptoms match.
• Fertility plans — want children soon or later?
• Baseline cardiometabolic risk and family/personal cancer history.
• Which TRT formulation fits your life and the monitoring plan.
• Alternatives to TRT (clomiphene, hCG) if fertility preservation is a priority.
• Plan for monitoring labs and dose adjustments.

Bottom line TRT can improve symptoms in men with true hypogonadism, but in your 30s the most important risks are suppressed fertility and potential long‑term cardiovascular and hematologic effects. Before starting, get a full evaluation (repeat morning testosterone, LH/FSH, CBC, metabolic panel), discuss fertility preservation (or use alternatives like clomiphene/hCG), and plan close laboratory monitoring with a urologist or endocrinologist. If you’d like, tell me whether you’re concerned about fertility, what symptoms you have, and whether you prefer injections or topical therapy — I can give more tailored information.